Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 15/20 | 0.63 |
| ▸ | QPCTL | Q9NXS2 | 3/20 | 0.40 |
| ▸ | MMP12 | P39900 | 1/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30245717 | 0.92 | QPCT (0.66) | QPCTQPCTLMMP12 | |
| SCHEMBL25424858 | 0.92 | QPCT (0.66) | QPCTQPCTLMMP12 | |
| SCHEMBL30245768 | 0.90 | QPCT (0.67) | QPCTQPCTLMMP12 | |
| SCHEMBL25426422 | 0.90 | QPCT (0.67) | QPCTQPCTLMMP12 | |
| SCHEMBL30245668 | 0.89 | QPCT (0.47) | QPCTMMP13 | |
| SCHEMBL25424065 | 0.88 | QPCT (0.67) | QPCTQPCTLMMP12MMP13SPHK1 | |
| SCHEMBL30245126 | 0.88 | QPCT (0.67) | QPCTQPCTLMMP12MMP13SPHK1 | |
| SCHEMBL25425601 | 0.86 | QPCT (0.67) | QPCTQPCTLMMP12SPHK1 | |
| SCHEMBL30245097 | 0.86 | QPCT (0.67) | QPCTQPCTLMMP12SPHK1 | |
| SCHEMBL30244953 | 0.86 | QPCT (0.75) | QPCTQPCTLMMP12SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384516-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | Texas Heart Institute (US) | 2024-06-19 | — | — | EP | claimed |
| WO-2023018472-A9 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-07-13 | — | — | WO | claimed |
| WO-2023018472-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-02-16 | — | — | WO | claimed |
| EP-4384516-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | Texas Heart Institute (US) | 2024-06-19 | — | — | EP | disclosed |
| WO-2023018472-A9 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023018472-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-02-16 | — | — | WO | disclosed |